机译:国际多中心血清蛋白电泳精度和M蛋白同学研究。 第二部分:小M-蛋白患者的检测和随访限制
Laboratory Medical Immunology Department of Laboratory Medicine Radboud University Medical Center;
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA;
Section of Clinical Biochemistry University of Verona Verona Italy;
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA;
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA;
Department of Chemical Pathology Pathology Queensland Royal Brisbane and Women’s Hospital;
Department of Pathology and Laboratory Medicine The Ottawa Hospital Ottawa ON Canada;
Department of Pathology and Laboratory Medicine The Ottawa Hospital Ottawa ON Canada;
Department of Pathology The University of Michigan Ann Arbor MI USA;
ARUP Laboratories Department of Pathology University of Utah School of Medicine Salt Lake City;
Clinical Chemistry Laboratory North Estonia Medical Centre Tallinn Estonia;
Department of Chemical Pathology The Royal Melbourne Hospital Melbourne Victoria Australia;
General Laboratory Careggi University Hospital Florence Italy;
NSW Health Pathology Immunology Department John Hunter Hospital New Lambton Heights NSW;
Immunopathology Department Royal Prince Alfred Hospital Camperdown NSW Australia;
Department of Chemical Pathology Pathology Queensland Royal Brisbane and Women’s Hospital;
Amyloidosis Research and Treatment Center Foundation IRCCS Policlinico San Matteo and Department;
Laboratory Medicine of the University Hospital of Padova Padova Italy;
Laboratory Medicine of the University Hospital of Padova Padova Italy;
Clinical Chemistry Laboratory University of Verona Verona Italy;
Sebia Inc. Lisses France;
Helena Biosciences Europe Sunderland UK;
Division of Clinical Biochemistry and Immunology Department of Laboratory Medicine and Pathology;
accuracy; immunofixation; immunosubtraction; limit of detection; monoclonal proteins; precision; protein electrophoresis;
机译:国际多中心血清蛋白电泳精度和M蛋白同学研究。 第二部分:小M-蛋白患者的检测和随访限制
机译:通过血清蛋白电泳检测IgA浓度与M蛋白值不同的IgA2-λ型M蛋白
机译:IgA2-Lambda型M蛋白的情况,IgA浓度与血清蛋白电泳的M蛋白的值不同
机译:体育药物检测中的治疗蛋白:通过(免疫)亲和纯化,胰蛋白酶消化和LCHRMS检测血清中不同的Actrii抑制剂
机译:端粒酶表达作为卵巢癌二期剖腹手术患者最小残留疾病检测的标志物:一项后续研究。
机译:在一项初步研究中完全清除血浆细胞骨髓瘤患者血清样品中的Daratumumab干扰可改善内源性M蛋白的检测。
机译:M-蛋白诊断的外部质量评估:M蛋白定量准确性和精度的逼真印象